Showing results (271-280 of 338) with videos related to
Sort By:
Pageof 34
Signal Transduction and Targeted Therapy|May 1, 2026
Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancerAnmbreen Jamroze, Xiaozhuo Liu, Surui Hou, et al.Clinical Chemistry|May 17, 2024
Rapid and Sensitive Detection of Fentanyl and Its Analogs by a Novel Chemiluminescence ImmunoassayJiang-Yang Zhao, Mezbah Uddin, Daisy Unsihuay, et al.Journal of Agricultural and Food Chemistry|June 5, 2020
Red Blood Cells and Lipoproteins: Important Reservoirs and Transporters of Polyphenols and Their MetabolitesSalwa M Harbi, Rania A Hussien, Intesar Hawasawi, et al.Abdominal Radiology (New York)|February 21, 2018
Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostateMahesh B Nagarajan, Steven S Raman, Pechin Lo, et al.Cancer Cell|April 7, 2016
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial CellsJohn K Lee, John W Phillips, Bryan A Smith, et al.Human Pathology|July 16, 2013
Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistryLindsay A Schelling, Sean R Williamson, Shaobo Zhang, et al.Biorxiv : the Preprint Server for Biology|November 26, 2025
NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancerUmar Mehraj, Uran Maimekov, Shaista Manzoor, et al.Cell Communication and Signaling : CCS|June 7, 2026
Co-targeting EGFR and SUCLG2 disrupts a nuclear transcriptional program driving neuroendocrine differentiation and TKI resistance in castration-resistant prostate cancerWei-Yu Chen, Kuan-Hua Huang, Gagan Kajla, et al.Molecular Cancer Research : MCR|June 9, 2017
Real-Time Transferrin-Based PET Detects MYC-Positive Prostate CancerRahul Aggarwal, Spencer C Behr, Pamela L Paris, et al.Cell Death & Disease|August 18, 2020
LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progressionMengfei Yao, Xiaolei Shi, Yue Li, et al.Pageof 34